Skip to main content

Table 1 Socio-demographic data of 2360 participants according to results of their SARS-CoV-2 anti-S

From: A pre-vaccine exploratory survey of SARS-CoV-2 humoral immunity among Egyptian general population

 

SARS-CoV-2 anti-S

p-value

Negative

Positive

Borderline

No.

%

No.

%

No.

%

Governorate

 Alexandria (30.3%)

396

55.4

295

41.3

24

3.4

0.236$

 Monufia (27.0)

355

55.7

259

40.7

23

3.6

 Cairo (9.2%)

122

56.0

92

42.2

4

1.8

 Giza (5.5%)

64

49.2

64

49.2

2

1.5

 Qalyubia (8.8%)

123

59.4

77

37.2

7

3.4

 Dakahlia (10.9%)

150

58.1

92

35.7

16

6.2

 Faiyum (4.2%)

33

33.0

67

67.0

0

0.0

 Suez (4.0%)

21

22.1

74

77.9

0

0.0

Gender

 Male (46.4%)

633

57.8

428

39.1

35

3.2

0.001*

 Female (53.6%)

631

49.9

592

46.8

41

3.2

Age (years)

 < 15 (19.4%)

241

52.7

208

45.5

8

1.8

0.328

 15–29 (18.3%)

227

52.5

183

42.4

22

5.1

 30–39 (17.6%)

227

54.7

174

41.9

14

3.4

 40–59 (32.6%)

412

53.5

334

43.4

24

3.1

 60+ (12.1%)

157

54.9

121

42.3

8

2.8

Residence

 Urban (51.2%)

630

52.1

552

45.7

27

2.2

0.008*

 Rural (37.1%)

492

56.2

346

39.5

37

4.2

 Slum (11.7%)

142

51.4

122

44.2

12

4.3

Education

 Illiterate (18.4%)

247

56.8

177

40.7

11

2.5

0.333

 Primary (15.0%)

187

53.0

158

44.8

8

2.3

 Preparatory (12.7%)

150

50.2

140

46.8

9

3.0

 Secondary (27.5%)

331

51.1

291

44.9

26

4.0

 University (26.5%)

349

55.8

254

40.6

22

3.5

Marital status

 Single (34.7%)

444

54.1

349

42.6

27

3.3

0.160$

 Married (57.8%)

739

54.1

580

42.5

46

3.4

 Divorced/widow (7.4%)

81

46.3

91

52.0

3

1.7

History of COVID-19 diagnosis#

 No (92.3%)

1223

56.2

885

40.6

70

3.2

0.001*

 Yes (7.7%)

41

22.5

135

74.2

6

3.3

History of PCR-confirmed COVID-19 infection

 No (98.6%)

1237

53.5

1001

43.3

76

3.3

0.410$

 Yes (1.4%)

27

58.7

19

41.3

0

0.0

  1. *P < 0.05 (significant) using Pearson X2 test, except “$” which indicates the use of exact probability test
  2. #Diagnosis based on any diagnostic means (clinical symptoms—laboratory biochemical and hematological parameters—rapid antigen test–PCR–chest CT)